Primaquine at alternative dosing schedules for preventing relapse in people with Plasmodium vivax malaria

R Milligan, A Daher, PM Graves - Cochrane Database of …, 2019 - cochranelibrary.com
Background Malaria caused by Plasmodium vivax requires treatment of the blood‐stage
infection and treatment of the hypnozoites that develop in the liver. This is a challenge to …

Primaquine at alternative dosing schedules for preventing relapse in people with Plasmodium vivax malaria.

R Milligan, A Daher, PM Graves - 2019 - cabidigitallibrary.org
Abstract Background: Malaria caused by Plasmodium vivax requires treatment of the blood-
stage infection and treatment of the hypnozoites that develop in the liver. This is a challenge …

Primaquine at alternative dosing schedules for preventing relapse in people with Plasmodium vivax malaria

R Milligan, A Daher, PM Graves - … Cochrane database of …, 2019 - pubmed.ncbi.nlm.nih.gov
Background Malaria caused by Plasmodium vivax requires treatment of the blood-stage
infection and treatment of the hypnozoites that develop in the liver. This is a challenge to …

[PDF][PDF] Primaquine at alternative dosing schedules for preventing relapse in people with Plasmodium vivaxmalaria

R Milligan, A Daher, PM Graves - status and date: New, published in, 2019 - core.ac.uk
Background Malaria caused by Plasmodium vivax requires treatment of the blood-stage
infection and treatment of the hypnozoites that develop in the liver. This is a challenge to …

[PDF][PDF] Primaquine at alternative dosing schedules for preventing relapse in people with Plasmodium vivax malaria

R Milligan, A Daher, PM Graves - Cochrane Database of …, 2017 - archive.lstmed.ac.uk
Primaquine at alternative dosing schedules for preventing relapse in people with
Plasmodium vivax malaria (Protocol) Page 1 Cochrane Database of Systematic Reviews …

[HTML][HTML] Primaquine at alternative dosing schedules for preventing relapse in people with Plasmodium vivax malaria

R Milligan, A Daher, PM Graves - The Cochrane Database of …, 2019 - ncbi.nlm.nih.gov
Background Malaria caused by Plasmodium vivax requires treatment of the blood‐stage
infection and treatment of the hypnozoites that develop in the liver. This is a challenge to …

Primaquine at alternative dosing schedules for preventing relapse in people with Plasmodium vivax malaria.

R Milligan, A Daher, PM Graves - The Cochrane Database of …, 2019 - europepmc.org
Background Malaria caused by Plasmodium vivax requires treatment of the blood-stage
infection and treatment of the hypnozoites that develop in the liver. This is a challenge to …

[HTML][HTML] Primaquine at alternative dosing schedules for preventing relapse in people with plasmodium vivax malaria

R Milligan, A Daher, PM Graves - Cochrane Database of …, 2019 - researchonline.jcu.edu.au
Background: Malaria caused by Plasmodium vivax requires treatment of the blood-stage
infection and treatment of the hypnozoites that develop in the liver. This is a challenge to …

[PDF][PDF] Primaquine at alternative dosing schedules for preventing relapse in people with Plasmodium vivax malaria

R Milligan, A Daher, PM Graves - status and date: New, published in, 2017 - academia.edu
Primaquine at alternative dosing schedules for preventing relapse in people with
Plasmodium vivax malaria (Protocol) Page 1 Cochrane Database of Systematic Reviews …

[PDF][PDF] Primaquine at alternative dosing schedules for preventing relapse in people with Plasmodium vivax malaria

R Milligan, A Daher, PM Graves - status and date: Unchanged …, 2019 - researchgate.net
Background Malaria caused by Plasmodium vivax requires treatment of the blood-stage
infection and treatment of the hypnozoites that develop in the liver. This is a challenge to …